BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 13, 2025
See today's BioWorld Asia
Home
» New biotech spinoff emerges from Anhui Anke, Shanghai Newsummit ¥55M JV
To read the full story,
subscribe
or
sign in
.
New biotech spinoff emerges from Anhui Anke, Shanghai Newsummit ¥55M JV
March 5, 2014
By
Cornelia Zou
HONG KONG – A Chinese biotechnology company is leading a group of investors, including many of its own top executives, in a joint venture to develop a sought-after drug used to regenerate skin cells in burn victims.
BioWorld Asia